Page results
-
Having proton beam therapy: information for children aged 9-12 patient information
-
This booklet tells you about having a Vortex® Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
Having proton beam therapy: information for children aged 5- 8 patient information leaflet
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a face-to-face appointment.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
-
This page tells you about having a PICC (Peripherally Inserted Central Catheter) line insertion with the Vascular Access team.
-
As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.
-
A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.
-
Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.
-
This information is for UCLH patients with cancer or a blood condition who are being offered a PICC (peripherally inserted central catheter).
File results
-
FOI/2023/0038 - Cases where breast milk of a new mother was given to a child who is not her own
-
FOI/2023/0041 - International recruitment
-
FOI/2023/0054 - Local formulary used at the Trust
-
FOI/2023/0058 - Skin cancer pathway management
-
FOI/2023/0063 - Women who have given birth at the Trust aged 50 or above
-
FOI/2023/0064 - Children's operations cancelled/ delayed for non-clinical reasons from 2018 to 2022
-
FOI/2023/0105 - Maternity services birthing centre
-
FOI/2023/0110 - General anaesthesia paediatric dental waiting times
-
FOI/2023/0109 - UK-EU aggrement S2 funding applications and treatments
-
FOI/2023/0111 - Migraine treatment